Acute pain management in patients with persistent pain

Current Opinion in Supportive and Palliative Care

Volumn 6, Issue 2, 2012, Pages 188-193

  Quinlan, Jane ^a   Carter, Kim ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute pain; Analgesia; Chronic pain; Opioid tolerant; Osteoporosis; Pancreatitis; Sphincter of Oddi

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ACUTE DISEASE; ANALGESIA; CHRONIC DISEASE; DOSE RESPONSE; DRUG TOLERANCE; FRAGILITY FRACTURE; HUMAN; METHODOLOGY; PAIN; PANCREATITIS; REVIEW; SICKLE CELL ANEMIA; VATER PAPILLA STENOSIS;

ACUTE DISEASE; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; HUMANS; OSTEOPOROTIC FRACTURES; PAIN; PAIN MANAGEMENT; PANCREATITIS; SPHINCTER OF ODDI DYSFUNCTION;

EID: 84863712079     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e3283520fb6     Document Type: Review

References (50)

1. Bannister K, Dickenson AH. Opioid hyperalgesia. Curr Opin Support Palliat Care 2010; 4:1-5.
2. Lee M, Silverman SM, Hansen H, et al. A comprehensive review of opioidinduced hyperalgesia. Pain Physician 2011; 14:145-161.
3. Huxtable CA, Roberts LJ, Somogyi AA, MacIntyre PE. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth Intensive Care 2011; 39:804-823.
4. Macintyre PE, Schug SA. Acute Pain Management: a practical guide. Churchill Livingstone: Elsevier; 2007.
5. Rapp SE, Ready LB, Nessly ML. Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review. Pain 1995; 61:195-201.
6. Macintyre PE, Schug SA, Scott DA, et al. Acute Pain Management: Scientific Evidence. 3rd ed. Melbourne: ANZCA & FPM; 2010.
7. DeOliveira GSJr, Almeida MD, Benzon HT, McCarthy RJ. Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology 2011; 115:575-588.
8. Turan A, Sessler DI. Steroids to ameliorate postoperative pain. Anesthesiology 2011; 115:457-459.
9. Wilkie DJ, Molokie R, Boyd-Seal D, et al. Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. J Natl Med Assoc 2010; 102:18-27.
10. Wright J, Ahmedzai SH. The management of painful crisis in sickle cell disease. Curr Opin Support Palliat Care 2010; 4:97-106.
11. Wang ZJ, Wilkie DJ, Molokie R. Neurobiological mechanisms of pain in sickle cell disease. Hematol Am Soc Hematol Educ Program 2010; 2010:403-408.
12. Rees DC, Olujohungbe AD, Parker NE, et al. Guidelines for the management of the acute painful crisis in sickle cell disease. British J Haematol 2003; 120:744-752. (Pubitemid 36315093)
13. Benjamin L, Dampier C, Jacox A. Guidelines for the Management of Acute and Chronic Pain in Sickle Cell Disease. APS Clinical Practice Guideline Series, No 1. Glenview, IL: American Pain Society; 1999.
14. Solomon LR. Pain Management in adults with sickle cell disease in a medical center emergency department. J Natl Med Assoc 2010; 102:1025-1032.
15. Field JJ, Knight-Perry JE, DeBaun MR. Acute pain in children and adults with sickle cell disease: management in the absence of evidence-based guidelines. Curr Opin Hematol 2009; 16:173-178.
16. Dunlop R, Bennett KCLB. Pain management for sickle cell disease in children and adults. Cochrane Database Syst Rev 2006: CD003350. doi: 10.1002/14651858.CD003350.pub2.
17. Dampier CD, Smith WR, Kim H-Y, et al. Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: A phase III analgesic trial for hospitalized sickle cell patients with painful episodes. Am J Hematol 2011; 86:E70-E73.
18. Peters-Lawrence MH, Bell MC, Hsu LL, et al. for the Sickle Cell Disease Clinical Research Network (SCDCRN). Clinical trial implementation and recruitment: Lessons learned from the early closure of a randomized clinical trial. Contemp Clin Trials 2012; 33:291-297.
19. Zempsky WT, Loiselle KA, Corsi JM, et al. Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series. Clin J Pain 2010; 26:163-167.
20. Meals CG, Mullican BD, Shaffer CM, et al. Ketamine infusion for sickle cell crisis pain in an adult. J Pain Symptom Manage 2011; 42:e7-e9.
21. Gladwin MT, Kato GJ, Weiner D, et al. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA 2011; 305:893-902.
22. Black LV, Smith WR. Evidence-Based Mini-Review: Are Systemic Corticosteroids an Effective Treatment for Acute Pain in Sickle Cell Disease? Hematology 2010; 2010:416-417.
23. Gutsaeva DR, Parkerson JB, Yerigenahally SD, et al. Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease. Blood 2011; 117:727-735.
24. Chang J, Patton JT, Sarkar A, et al. GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice. Blood 2010; 116:1779-1786.
25. Smith WR, Jordan LB, Hassell KL. Frequently asked questions by hospitalists managingpaininadultswithsicklecelldisease. J Hosp Med 2011;6:297-303.
26. Chauhan S, Forsmark CE. Pain management in chronic pancreatitis: A treatment algorithm. Best Pract Res Clin Gastroenterol 2010; 24:323-335.
27. Hackert T, Werner J. Antioxidant therapy in acute pancreatitis: Experimental and clinical evidence. Antioxid Redox Signal 2011; 15:2767-2777.
28. Bhardwaj P, Garg PK, Maulik SK, et al. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009; 136:149-159.
29. Booth DM, Mukherjee R, Sutton R, Criddle DN. Calcium and reactive oxygen species in acute pancreatitis: Friend or foe? Antioxid Redox Signal 2011; 15:2683-2698.
30. Kapural L, Cywinski JB, Sparks DA. Spinal cord stimulation for visceral pain from chronic pancreatitis. Neuromodulation 2011; 14:423-427.
31. Baillie J. Sphincter of Oddi Dysfunction. Curr Gastroenterol Rep 2010; 12:130-134.
32. Craig A, Toouli J. Sphincter of Oddi dysfunction: is there a role for medical therapy? Curr Gastroenterol Rep 2002; 4:172-176.
33. Piccini G, Angrisano A, Testini M, Bonomo GM. Diagnosing and treating Sphincter of Oddi dysfunction. J Clin Gastroenterol 2004; 38:350-359.
34. Kalaitzakis E, Ambrose T, Phillips-Hughes J, et al. Management of patients with biliary sphincter of Oddi disorder without sphincter of Oddi manometry. BMC Gastroenterol 2010; 10:124.
35. Cheon YK, Cho YD, Moon JH, et al. Effects ofvardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction. Gastrointest Endosc 2009; 69:1111-1116.
36. Lacy BE, Weiser K, Kennedy A. Botulinum Toxin and Gastrointestinal Tract Disorders: Panacea, Placebo, or Pathway to the Future? Gastroenterol Hepatol 2008; 4:283-295. (Pubitemid 351656355)
37. McWilliams L, Goodwin R, Cox B. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 2004; 111:77-83. (Pubitemid 39141009)
38. Kovács Z, Kovács F, Pap Á, Czobor P. Sphincter of Oddi dysfunction: Does Psychosocial Distress Play a Role? J Clin Psychol Med Settings 2006; 14:138-144.
39. Winstead NS, Wilcox CM. Health-related Quality of Life, Somatization, and Abuse in Sphincter of Oddi Dysfunction. J Clin Gastroenterol 2007; 41:773-776. (Pubitemid 47267764)
40. Kovács Z, Seres G, Kerékgyártó O, Czobor P. Psychopathological Symptom Dimensions in Patients with Gastrointestinal Disorders. J Clin Psych Med Settings 2010; 17:378-386.
41. Farre M, Cami J. Pharmacokinetic considerations in abuse liability evaluation. Br J Addict 1991; 86:1601-1606.
42. Cami J, Farre M. Drug addiction. N Engl J Med 2003; 349:975-986.
43. Ballantyne JC, LaForge SL. Opioid dependence and addiction in opioid treated pain patients. Pain 2007; 129:235-255. (Pubitemid 46754581)
44. Ballantyne JC, Fleisher LA. Ethical issues in opioid prescribing for chronic pain. Pain 2010; 148:365-367.
45. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010; 152:85-92.
46. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011; 305: 1315-1321.
47. Felsenberg D, Silman AJ, Lunt M, et al. EPOS Group 2002 Incidence of vertebral fracture in Europe. J Bone Miner Res 2002; 17:716-724.
48. Knopp-Sihota JA, Newburn-Cook CV, Homik J, et al. Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis. Osteoporos Int 2011; 23:17-38.
49. Klazen CAH, Lohle PNM, Vries J, et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. Lancet 2010; 376:1085-1092.
50. Boyle N, Naganathan V, Cumming RG. Medication and falls: risk and optimization. Clin Geriatr Med 2010; 26:583-605.